Advertisement
Singapore markets closed
  • Straits Times Index

    3,338.97
    -9.90 (-0.30%)
     
  • S&P 500

    5,283.40
    +5.89 (+0.11%)
     
  • Dow

    38,571.03
    -115.27 (-0.30%)
     
  • Nasdaq

    16,828.67
    +93.67 (+0.56%)
     
  • Bitcoin USD

    68,726.44
    -417.96 (-0.60%)
     
  • CMC Crypto 200

    1,444.98
    -2.17 (-0.15%)
     
  • FTSE 100

    8,210.76
    -51.99 (-0.63%)
     
  • Gold

    2,353.10
    -16.20 (-0.68%)
     
  • Crude Oil

    72.79
    -1.43 (-1.93%)
     
  • 10-Yr Bond

    4.4020
    -0.1120 (-2.48%)
     
  • Nikkei

    38,837.46
    -85.54 (-0.22%)
     
  • Hang Seng

    18,444.11
    +41.11 (+0.22%)
     
  • FTSE Bursa Malaysia

    1,615.40
    +18.72 (+1.17%)
     
  • Jakarta Composite Index

    7,110.86
    +74.67 (+1.06%)
     
  • PSE Index

    6,386.42
    -84.32 (-1.30%)
     

Shareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years ago

Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So spare a thought for the long term shareholders of Clarivate Plc (NYSE:CLVT); the share price is down a whopping 74% in the last three years. That would be a disturbing experience. Furthermore, it's down 25% in about a quarter. That's not much fun for holders.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

View our latest analysis for Clarivate

Clarivate wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually desire strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

ADVERTISEMENT

In the last three years, Clarivate saw its revenue grow by 23% per year, compound. That is faster than most pre-profit companies. So on the face of it we're really surprised to see the share price down 20% a year in the same time period. The share price makes us wonder if there is an issue with profitability. Ultimately, revenue growth doesn't amount to much if the business can't scale well. Unless the balance sheet is strong, the company might have to raise capital.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
earnings-and-revenue-growth

Clarivate is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.

A Different Perspective

Investors in Clarivate had a tough year, with a total loss of 11%, against a market gain of about 28%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. However, the loss over the last year isn't as bad as the 8% per annum loss investors have suffered over the last half decade. We'd need to see some sustained improvements in the key metrics before we could muster much enthusiasm. You might want to assess this data-rich visualization of its earnings, revenue and cash flow.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.